Stephen Hoge
Förmögenhet: 77 M $ per 2026-05-31
Förmögenhet: 77 M $ per 2026-05-31
Stephen Hoge is currently President at ModernaTX, Inc. and President at Moderna, Inc. since 2024.
Former positions include Independent Director at Axcella Health, Inc. from 2014 to 2022 and Partner at McKinsey & Co., Inc. from 2010 to 2012.
Education includes undergraduate studies at Amherst College and a doctorate from The University of California, San Francisco, conferred in 2003.
| Företag | Datum | Antal aktier | Värdering | Värderingsdatum |
|---|---|---|---|---|
MODERNA, INC. 0,41 % | 2026-06-15 | 1 639 897 ( 0,41 % ) | 77 M $ | 2026-05-31 |
| Företag | Position | Start |
|---|---|---|
| MODERNA, INC. | President | 2024-11-01 |
ModernaTX, Inc.
ModernaTX, Inc. BiotechnologyHealth Technology Develops messenger RNA therapeutics | President | - |
| Företag | Position | Slut |
|---|---|---|
| AXCA HEALPAR | Direktör/Styrelseledamot | 2022-05-19 |
McKinsey & Co., Inc.
McKinsey & Co., Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a management consulting firm | Företagsledare/Principal | 2012-12-01 |
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Första gradens relationer
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
| Privata företag | 6 |
|---|---|
McKinsey & Co., Inc.
McKinsey & Co., Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a management consulting firm | Commercial Services |
Amherst College
Amherst College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The University of California, San Francisco
The University of California, San Francisco Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
ModernaTX, Inc.
ModernaTX, Inc. BiotechnologyHealth Technology Develops messenger RNA therapeutics | Health Technology |
Axcella Health, Inc.
Axcella Health, Inc. BiotechnologyHealth Technology Provides first-in-class precision therapeutic solutions to diseases with a focus on restoring amino acid biology | Health Technology |
Moderna, Inc.
Moderna, Inc. BiotechnologyHealth Technology Researches, develops, manufactures and commercializes mRNA-based respiratory & other virus vaccines, oncology and rare disease therapeutics | Health Technology |
Välj din utgåva
All finansiell information anpassad till den nationella nivån